Abstract: A method of hemostasis includes the step of applying a hemostatic agent to an affected site of a subject, the hemostatic agent consisting of a first agent comprising a gelatin derivative having a hydrophobic group bonded to the gelatin via an imino group, wherein the gelatin derivative has (a) a weight average molecular weight of from 10,000 to 50,000, (b) the hydrophobic group, which is an alkyl group having 6 to 18 carbon atoms; and (c) a molar ratio of imino group/amino group of the gelatin derivative ranging from 1/99 to 30/70; and a second agent including a crosslinking agent for the gelatin derivative.

Abstract: The present invention provides an oxynitride phosphor represented by a composition formula M(1)1?jM(2)jSibAlcOdNe (composition formula I) or a composition formula M(1)1?a?jM(2)jCeaSibAlcOdNe (composition formula II) and containing 50% or more of a JEM phase, and a light emitting device including a semiconductor light emitting element emitting an excited light, a first phosphor that is the oxynitride phosphor according to the present invention that absorbs the excited light and emits a fluorescence, and a kind or a plurality of kinds of second phosphor(s) that absorb(s) the excited light and emit(s) a fluorescence having a longer wavelength than the fluorescence emitted by the first phosphor. Thereby, a novel oxynitride phosphor being capable of highly efficiently emitting mainly a light having a wavelength of 510 nm or less and a light emitting device using the same can be provided.